Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Impact of pharmacotherapeutic education on medication adherence and adverse outcomes in patients with type 2 diabetes mellitus: a prospective, randomized study.

Marušić S, Meliš P, Lucijanić M, Grgurević I, Turčić P, Neto PRO, Bilić-Ćurčić I.

Croat Med J. 2018 Dec 31;59(6):290-297.

2.

Celiac disease-specific and inflammatory bowel disease-related antibodies in patients with recurrent aphthous stomatitis.

Bijelić B, Matić IZ, Besu I, Janković L, Juranić Z, Marušić S, Andrejević S.

Immunobiology. 2018 Nov 2. pii: S0171-2985(18)30176-1. doi: 10.1016/j.imbio.2018.10.006. [Epub ahead of print]

PMID:
30446336
3.

Ultrasound Grade of Liver Steatosis Is Independently Associated with the Risk of Metabolic Syndrome.

Mustapic S, Ziga S, Matic V, Bokun T, Radic B, Lucijanic M, Marusic S, Babic Z, Grgurevic I.

Can J Gastroenterol Hepatol. 2018 Aug 23;2018:8490242. doi: 10.1155/2018/8490242. eCollection 2018.

4.

Pharmacist's interventions improve time in therapeutic range of elderly rural patients on warfarin therapy: a randomized trial.

Falamić S, Lucijanić M, Hadžiabdić MO, Marušić S, Bačić Vrca V.

Int J Clin Pharm. 2018 Oct;40(5):1078-1085. doi: 10.1007/s11096-018-0691-z. Epub 2018 Jul 26.

PMID:
30051222
5.

Effect of timing of levothyroxine administration on the treatment of hypothyroidism: a three-period crossover randomized study.

Skelin M, Lucijanić T, Liberati-Čizmek AM, Klobučar SM, Lucijanić M, Jakupović L, Bakula M, Lončar JV, Marušić S, Matić T, Romić Ž, Dumić J, Rahelić D.

Endocrine. 2018 Nov;62(2):432-439. doi: 10.1007/s12020-018-1686-1. Epub 2018 Jul 24.

PMID:
30043093
6.

Implementation of Venous Thromboembolism Prophylaxis Guidelines in Clinical Practice: A Retrospective Study in Two Croatian Hospitals.

Marušić S, Knežević A, Bačić Vrca V, Marinović I, Bačić J, Obreli Neto PR, Amidžić Klarić D, Diklić D.

Acta Clin Croat. 2017 Dec;56(4):657-662. doi: 10.20471/acc.2017.56.04.12.

PMID:
29590720
7.

The effectiveness of lixisenatide as an add on therapy to basal insulin in diabetic type 2 patients previously treated with different insulin regimes: a multi-center observational study.

Božek T, Bilić-Ćurčić I, Berković MC, Gradišer M, Kurir TT, Majanović SK, Marušić S.

Diabetol Metab Syndr. 2018 Mar 13;10:16. doi: 10.1186/s13098-018-0321-x. eCollection 2018.

8.

RVX-297, a BET Bromodomain Inhibitor, Has Therapeutic Effects in Preclinical Models of Acute Inflammation and Autoimmune Disease.

Jahagirdar R, Attwell S, Marusic S, Bendele A, Shenoy N, McLure KG, Gilham D, Norek K, Hansen HC, Yu R, Tobin J, Wagner GS, Young PR, Wong NCW, Kulikowski E.

Mol Pharmacol. 2017 Dec;92(6):694-706. doi: 10.1124/mol.117.110379. Epub 2017 Sep 29.

PMID:
28974538
9.
10.

ROCK2 signaling is required to induce a subset of T follicular helper cells through opposing effects on STATs in autoimmune settings.

Weiss JM, Chen W, Nyuydzefe MS, Trzeciak A, Flynn R, Tonra JR, Marusic S, Blazar BR, Waksal SD, Zanin-Zhorov A.

Sci Signal. 2016 Jul 19;9(437):ra73. doi: 10.1126/scisignal.aad8953.

11.

NEUROBIOLOGICAL BASES OF ALCOHOL ADDICTION.

Matošić A, Marušić S, Vidrih B, Kovak-Mufić A, Cicin-Šain L.

Acta Clin Croat. 2016 Mar;55(1):134-50. Review.

PMID:
27333729
12.

Ventricular tachycardia: ominous sign of devastating prosthetic aortic valve dehiscence.

Sicaja M, Baric D, Unic D, Marusic S, Vincelj J, Sicaja MN, Starcevic B.

Ann Saudi Med. 2015 Nov-Dec;35(6):472-4. doi: 10.5144/0256-4947.2015.472.

13.

Crowd Event Detection on Optical Flow Manifolds.

Rao AS, Gubbi J, Marusic S, Palaniswami M.

IEEE Trans Cybern. 2016 Jul;46(7):1524-37. doi: 10.1109/TCYB.2015.2451136. Epub 2015 Jul 23.

PMID:
26219100
14.

Research Integrity and Research Ethics in Professional Codes of Ethics: Survey of Terminology Used by Professional Organizations across Research Disciplines.

Komić D, Marušić SL, Marušić A.

PLoS One. 2015 Jul 20;10(7):e0133662. doi: 10.1371/journal.pone.0133662. eCollection 2015.

15.

Mentoring--hard and underappreciated but rewarding.

Marusic S.

Acta Med Acad. 2015;44(1):79-80. doi: 10.5644/ama2006-124.131. No abstract available.

16.

Economic evaluation of a pharmaceutical care program for elderly diabetic and hypertensive patients in primary health care: a 36-month randomized controlled clinical trial.

Obreli-Neto PR, Marusic S, Guidoni CM, Baldoni Ade O, Renovato RD, Pilger D, Cuman RK, Pereira LR.

J Manag Care Spec Pharm. 2015 Jan;21(1):66-75.

17.

Large chondrosarcoma of the lumbar spine--a rare yet important cause of lower back pain.

Franić M, Dokuzović S, Marušić S, Kovaĉ V.

Coll Antropol. 2014 Sep;38(3):1039-42.

PMID:
25420391
18.

Adverse drug reactions in elderly patients following discharge from an internal medicine clinic.

Marusic S, Sicaja M, Obreli Neto PR, Franic M, Marinovic I, Bacic-Vrca V.

Int J Clin Pharmacol Ther. 2014 Oct;52(10):906-13. doi: 10.5414/CP202041.

PMID:
25066228
19.

Peripheral mononeuropathy associated with valproic acid poisoning in an adult patient.

Marusic S, Obreli Neto PR, Vuletic V, Kirin M.

Int J Clin Pharmacol Ther. 2014 Sep;52(9):802-4. doi: 10.5414/CP202074.

PMID:
24800920
20.

Focal myositis of lower extremity responsive to botulinum A toxin.

Mitrovic J, Prka Z, Zic R, Marusic S, Morovic-Vergles J.

Clin Neuropharmacol. 2014 Mar-Apr;37(2):55-7. doi: 10.1097/WNF.0000000000000019.

PMID:
24614669
21.

Human endogenous retrovirus protein activates innate immunity and promotes experimental allergic encephalomyelitis in mice.

Perron H, Dougier-Reynaud HL, Lomparski C, Popa I, Firouzi R, Bertrand JB, Marusic S, Portoukalian J, Jouvin-Marche E, Villiers CL, Touraine JL, Marche PN.

PLoS One. 2013 Dec 6;8(12):e80128. doi: 10.1371/journal.pone.0080128. eCollection 2013.

22.

Use of simulated patients to evaluate combined oral contraceptive dispensing practices of community pharmacists.

Obreli-Neto PR, Pereira LR, Guidoni CM, de Oliveira Baldoni A, Marusic S, de Lyra-Júnior DP, de Almeida KL, Pazete AC, do Nascimento JD, Kos M, Girotto E, Cuman RK.

PLoS One. 2013 Dec 4;8(12):e79875. doi: 10.1371/journal.pone.0079875. eCollection 2013.

23.

The relationship between methylenetetrahydrofolate reductase C677T gene polymorphism and diabetic nephropathy in Croatian type 2 diabetic patients.

Tomić NG, Marusić S, Bozikov V, Kusec R, Bacić-Vrca V, Tadić M.

Coll Antropol. 2013 Sep;37(3):789-93.

PMID:
24308218
24.

Actual drug-drug interactions in elderly patients discharged from internal medicine clinic: a prospective observational study.

Marusic S, Bacic-Vrca V, Obreli Neto PR, Franic M, Erdeljic V, Gojo-Tomic N.

Eur J Clin Pharmacol. 2013 Sep;69(9):1717-24. doi: 10.1007/s00228-013-1531-7. Epub 2013 Jun 6.

PMID:
23739998
25.

Atorvastatin-related rhabdomyolysis and acute renal failure in a genetically predisposed patient with potential drug-drug interaction.

Marusic S, Lisicic A, Horvatic I, Bacic-Vrca V, Bozina N.

Int J Clin Pharm. 2012 Dec;34(6):825-7. doi: 10.1007/s11096-012-9717-0. Epub 2012 Oct 18.

PMID:
23076661
26.

The effect of pharmacotherapeutic counseling on readmissions and emergency department visits.

Marusic S, Gojo-Tomic N, Erdeljic V, Bacic-Vrca V, Franic M, Kirin M, Bozikov V.

Int J Clin Pharm. 2013 Feb;35(1):37-44. doi: 10.1007/s11096-012-9700-9. Epub 2012 Sep 25.

PMID:
23007693
27.

Enhanced anticoagulant effect of warfarin in a patient treated with cloxacillin.

Marusic S, Gojo-Tomic N, Bacic-Vrca V, Franic M.

Int J Clin Pharmacol Ther. 2012 Jun;50(6):431-3.

PMID:
22677303
28.

Prevalence and predictors of potential drug-drug interactions in the elderly: a cross-sectional study in the brazilian primary public health system.

Obreli Neto PR, Nobili A, Marusic S, Pilger D, Guidoni CM, Baldoni Ade O, Cruciol-Souza JM, Da Cruz AN, Gaeti WP, Cuman RK.

J Pharm Pharm Sci. 2012;15(2):344-54.

29.

Antioxidant supplementation and serum lipids in patients with Graves' disease: effect on LDL-cholesterol.

Vrca VB, Mayer L, Skreb F, Rahelić D, Marušić S.

Acta Pharm. 2012 Mar;62(1):115-22. doi: 10.2478/v10007-012-0005-2.

PMID:
22472454
30.

Impact of ceftriaxone de-restriction on the occurrence of ESBL-positive bacterial strains and antibiotic consumption.

Skrlin J, Bacic Vrca V, Marusic S, Ciric-Crncec M, Mayer L.

J Chemother. 2011 Dec;23(6):341-4.

PMID:
22233817
31.

Cytosolic phospholipase A2α blockade abrogates disease during the tissue-damage effector phase of experimental autoimmune encephalomyelitis by its action on APCs.

Thakker P, Marusic S, Stedman NL, Lee KL, McKew JC, Wood A, Goldman SJ, Leach MW, Collins M, Kuchroo VK, Wolf SF, Clark JD, Hassan-Zahraee M.

J Immunol. 2011 Aug 15;187(4):1986-97. doi: 10.4049/jimmunol.1002789. Epub 2011 Jul 11.

32.

Effect of a 36-month pharmaceutical care program on the coronary heart disease risk in elderly diabetic and hypertensive patients.

Neto PR, Marusic S, de Lyra Júnior DP, Pilger D, Cruciol-Souza JM, Gaeti WP, Cuman RK.

J Pharm Pharm Sci. 2011;14(2):249-63.

33.

Hyperkalaemia associated with hydroxyurea in a patient with polycythaemia vera.

Marusic S, Gojo-Tomic N, Bacic-Vrca V, Bozikov V.

Eur J Clin Pharmacol. 2011 Jul;67(7):757-8. doi: 10.1007/s00228-010-0962-7. Epub 2010 Dec 14. No abstract available.

PMID:
21153897
34.

The incidence of potential drug-drug interactions in elderly patients with arterial hypertension.

Bacic-Vrca V, Marusic S, Erdeljic V, Falamic S, Gojo-Tomic N, Rahelic D.

Pharm World Sci. 2010 Dec;32(6):815-21. doi: 10.1007/s11096-010-9442-5. Epub 2010 Oct 5.

PMID:
20922479
35.

Mice lacking Tbk1 activity exhibit immune cell infiltrates in multiple tissues and increased susceptibility to LPS-induced lethality.

Marchlik E, Thakker P, Carlson T, Jiang Z, Ryan M, Marusic S, Goutagny N, Kuang W, Askew GR, Roberts V, Benoit S, Zhou T, Ling V, Pfeifer R, Stedman N, Fitzgerald KA, Lin LL, Hall JP.

J Leukoc Biol. 2010 Dec;88(6):1171-80. doi: 10.1189/jlb.0210071. Epub 2010 Jul 22.

PMID:
20651301
36.

Anti-PR3 immune responses induce segmental and necrotizing glomerulonephritis.

Primo VC, Marusic S, Franklin CC, Goldmann WH, Achaval CG, Smith RN, Arnaout MA, Nikolic B.

Clin Exp Immunol. 2010 Mar;159(3):327-37. doi: 10.1111/j.1365-2249.2009.04072.x. Epub 2009 Dec 14.

37.

Leukocytoclastic vasculitis associated with insulin aspart in a patient with type 2 diabetes.

Marusic S, Vlahovic-Palcevski V, Ljubanovic D.

Int J Clin Pharmacol Ther. 2009 Oct;47(10):603-5.

PMID:
19825323
38.

Therapeutic efficacy of acenocoumarol in a warfarin-resistant patient with deep venous thrombosis: a case report.

Marusic S, Gojo-Tomic N, Franic M, Bozina N.

Eur J Clin Pharmacol. 2009 Dec;65(12):1265-6. doi: 10.1007/s00228-009-0710-z. No abstract available.

PMID:
19652960
39.

Selective inhibitors of tumor progression loci-2 (Tpl2) kinase with potent inhibition of TNF-alpha production in human whole blood.

Wu J, Green N, Hotchandani R, Hu Y, Condon J, Huang A, Kaila N, Li HQ, Guler S, Li W, Tam SY, Wang Q, Pelker J, Marusic S, Hsu S, Perry Hall J, Telliez JB, Cui J, Lin LL.

Bioorg Med Chem Lett. 2009 Jul 1;19(13):3485-8. doi: 10.1016/j.bmcl.2009.05.009. Epub 2009 May 7.

PMID:
19464884
40.

The utilization of antibiotics in the management of acute pancreatitis--experience from one transitional country university hospital.

Marusić S, Sićaja M, Kujundzić M, Banić M, Jaksić O, Vrazić H.

Coll Antropol. 2008 Dec;32(4):1189-94.

PMID:
19149227
41.

Blockade of cytosolic phospholipase A2 alpha prevents experimental autoimmune encephalomyelitis and diminishes development of Th1 and Th17 responses.

Marusic S, Thakker P, Pelker JW, Stedman NL, Lee KL, McKew JC, Han L, Xu X, Wolf SF, Borey AJ, Cui J, Shen MW, Donahue F, Hassan-Zahraee M, Leach MW, Shimizu T, Clark JD.

J Neuroimmunol. 2008 Nov 15;204(1-2):29-37. doi: 10.1016/j.jneuroim.2008.08.012.

PMID:
18829119
42.

Alcohol dependence and polymorphisms of serotonin-related genes: association studies.

Mokrović G, Matosić A, Hranilović D, Stefulj J, Novokmet M, Oresković D, Balija M, Marusić S, Cicin-Sain L.

Coll Antropol. 2008 Jan;32 Suppl 1:127-31.

PMID:
18405071
43.

Platelet monoamine oxidase kinetics, alcoholism subtypes and cigarette smoking.

Cicin-Sain L, Matosic A, Mokrovic G, Balija M, Marusic S, Jernej B.

Neuropsychobiology. 2007;56(2-3):138-45. doi: 10.1159/000115780. Epub 2008 Feb 7.

PMID:
18259087
44.

Inhibitors of tumor progression loci-2 (Tpl2) kinase and tumor necrosis factor alpha (TNF-alpha) production: selectivity and in vivo antiinflammatory activity of novel 8-substituted-4-anilino-6-aminoquinoline-3-carbonitriles.

Green N, Hu Y, Janz K, Li HQ, Kaila N, Guler S, Thomason J, Joseph-McCarthy D, Tam SY, Hotchandani R, Wu J, Huang A, Wang Q, Leung L, Pelker J, Marusic S, Hsu S, Telliez JB, Hall JP, Cuozzo JW, Lin LL.

J Med Chem. 2007 Sep 20;50(19):4728-45. Epub 2007 Aug 23.

PMID:
17715908
45.

IL-23 is critical in the induction but not in the effector phase of experimental autoimmune encephalomyelitis.

Thakker P, Leach MW, Kuang W, Benoit SE, Leonard JP, Marusic S.

J Immunol. 2007 Feb 15;178(4):2589-98.

46.

PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis.

Carter LL, Leach MW, Azoitei ML, Cui J, Pelker JW, Jussif J, Benoit S, Ireland G, Luxenberg D, Askew GR, Milarski KL, Groves C, Brown T, Carito BA, Percival K, Carreno BM, Collins M, Marusic S.

J Neuroimmunol. 2007 Jan;182(1-2):124-34. Epub 2006 Dec 19.

PMID:
17182110
47.

The mitogen-activated protein kinase (MAPK)-activated protein kinases MK2 and MK3 cooperate in stimulation of tumor necrosis factor biosynthesis and stabilization of p38 MAPK.

Ronkina N, Kotlyarov A, Dittrich-Breiholz O, Kracht M, Hitti E, Milarski K, Askew R, Marusic S, Lin LL, Gaestel M, Telliez JB.

Mol Cell Biol. 2007 Jan;27(1):170-81. Epub 2006 Oct 9.

48.

[Doxycycline induced esophageal ulcers: report of two cases and review of the literature].

Grgurević I, Marusić S, Banić M, Buljevac M, Crncevic-Urek M, Cabrijan Z, Kardumz D, Kujundzić M, Lesnjaković I, Tadić M, Loncar B.

Lijec Vjesn. 2005 Nov-Dec;127(11-12):285-7. Review. Croatian.

PMID:
16583934
49.

Exploiting genotypic differences to identify genes important for EAE development.

Jelinsky SA, Miyashiro JS, Saraf KA, Tunkey C, Reddy P, Newcombe J, Oestreicher JL, Brown E, Trepicchio WL, Leonard JP, Marusic S.

J Neurol Sci. 2005 Dec 15;239(1):81-93. Epub 2005 Oct 7.

PMID:
16214174
50.

Cytosolic phospholipase A2 alpha-deficient mice are resistant to experimental autoimmune encephalomyelitis.

Marusic S, Leach MW, Pelker JW, Azoitei ML, Uozumi N, Cui J, Shen MW, DeClercq CM, Miyashiro JS, Carito BA, Thakker P, Simmons DL, Leonard JP, Shimizu T, Clark JD.

J Exp Med. 2005 Sep 19;202(6):841-51.

Supplemental Content

Loading ...
Support Center